News

New surveillance report sheds light on meningococcal disease rates among HIV-infected MSM.

In allogenic hematopoietic cell transplant patients, auto-FMT treatment led to the recovery of beneficial gut bacteria close to baseline levels within days.

Plenty of research has gone into the causes and progression of Alzheimer’s disease. Now a new effort aims to make the case that scientists have been looking in the wrong direction.

A new report from the CDC underscores the need for all pregnant women to receive early prenatal care that includes syphilis testing at their first visit.

Contamination is a common aspect of nasal saline irrigations.

Using an algorithm to determine course of treatment shortened antibiotic use by 2 days for patients with uncomplicated staphylococcal bacteremia infections.

Despite big advances in the field of HIV treatment, including streamlined drug regimens that help infected people achieve normal or near-normal lifespans, living with HIV often means dealing with neurocognitive impairment of some kind.

The NIH has launched a phase 1 trial evaluating whether it is safe to administer infusions of 2 broadly neutralizing antibodies (bNAbs) in people living with HIV.

Hepatitis A outbreaks are active in 13 states across the United States, yet vaccination is required in only a fraction of them.

Even as new treatments for the virus become available, access may be an issue thanks to budget re-shuffling in Washington.

New research published in The BMJ indicates that the Pandemrix vaccine was linked with 5 times the number of adverse events reported from 2 other pandemic vaccines.

The FDA has granted QIDP and fast track designations to Cidara Therapeutics’ prophylaxis development program for rezafungin, their lead antifungal product candidate.

Global health officials are concerned about the potential consequences of the disruption to Ebola surveillance in the DRC outbreak caused by civil unrest.

As millennials communicate extensively by text, investigators designed a study to improve rates of retention and medication adherence in young men who have sex with men.

In a new study, investigators say cases of uncomplicated acute appendicitis may be treatable with antibiotics alone in place of appendectomy.

Scientists sought to figure out whether rapid diagnostic tests could be used to determine the susceptibility of P aeruginosa to 2 new therapies. The answer was yes, but with caveats.

Investigators find iclaprim to be active against a worldwide collection of drug-susceptible and drug-resistant beta-hemolytic streptococci from patients with skin and skin structure infections.

A recent study by the Kirby Institute reported that after using direct-acting antiviral therapy 97% of participants with HCV who recently used injectable drugs achieved sustained viral response.

What you should know before you travel this winter season.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

During the month of July, individuals in 4 states were found to have Shiga toxin-producing E coli O26 connected to contaminated ground beef consumption.

Investigators have discovered a genetic mutation that increases the burden of Aspergillus fumigatus and can lead to complications for patients with asthma.

HIV-specific ex-vivo expanded T cell therapy appears to be safe and well tolerated in people with HIV taking antiretroviral therapy who are virally suppressed.

By itself, the POET trial should not fundamentally change the current approach to infective endocarditis treatment.

During a multidrug-resistant Campylobacter outbreak, 142 puppies were identified as receiving 1 or more antibiotic courses before arriving or while at the store.

An examination of 17 years of data reveals that children who received the combination acellular vaccine Tdap were vulnerable to pertussis much earlier than expected. Researchers are hopeful that new vaccines will extend protection against the disease.

Patients with diabetes who were treated for acute bacterial skin and skin structure infections (ABSSSIs) with iclaprim had fewer adverse events (AEs) than those who were treated with vancomycin, according to the results of a recent study.

In August 2017, the FDA granted an NDA for a single-use of delamanid for a case of extensively drug-resistant tuberculosis.

Duodenoscopes are at fault for another infectious disease outbreak, and this time it's with a highly-resistant bacteria.